PreMD’s intellectual property (IP) is a key asset that protects innovation and preserves the value of our products. Indeed, strong intellectual property protection is essential to the success of any company in the biotechnology industry. We have aggressively pursued patent protection in Canada, the United States and other significant world markets for all of our products.

We maintain a diverse IP portfolio, comprised of numerous patents and patents pending, trademarks, trade secrets and technological know-how.

Our portfolio includes:

• 38 issued patents and patents pending related to skin cholesterol;
• 22 patents and patents pending related to our cancer technologies; and
• Nine patents and patents pending related to the color-measurement process, which is employed across our product lines.